Evaluation of Krebs cycle enzymes in the brain of rats after chronic administration of antidepressants

Brain Research Bulletin

Volumn 82, Issue 3-4, 2010, Pages 224-227

  Scaini, Giselli ^a,b   Santos, Patricia M ^a,b   Benedet, Joana ^a,b   Rochi, Natália ^a,b   Gomes, Lara M ^a,b   Borges, Lislaine S ^a,b   Rezin, Gislaine T ^a,b   Pezente, Daiana P ^a,b   Quevedo, João ^a,b   Streck, Emilio L ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Instituto Brasileiro de Informagào em Ciencia e Tecnologia   (Brazil)

Author keywords

Brain; Citrate synthase; Nortriptiline; Paroxetine; Succinate dehydrogenase; Venlafaxine

Indexed keywords

CITRATE SYNTHASE; NORTRIPTYLINE; PAROXETINE; SODIUM CHLORIDE; SUCCINATE DEHYDROGENASE; VENLAFAXINE; ANTIDEPRESSANT AGENT; CYCLOHEXANOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CEREBELLUM; CHRONIC DRUG ADMINISTRATION; CITRIC ACID CYCLE; CONTROLLED STUDY; CORPUS STRIATUM; DECAPITATION; DEPRESSION; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME METABOLISM; HIPPOCAMPUS; INJECTION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; WISTAR RAT; ANATOMY AND HISTOLOGY; ANIMAL; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CITRATE (SI)-SYNTHASE; CITRIC ACID CYCLE; CYCLOHEXANOLS; MALE; NORTRIPTYLINE; PAROXETINE; RATS; RATS, WISTAR; SUCCINATE DEHYDROGENASE;

EID: 77953614169     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2010.03.006     Document Type: Article

References (37)

1. Albert K.A., Hemmings H.C., Adamo A.I., Potkin S.G., Akbarian S., Sandman C.A., Cotman C.W., Bunney JR W.E., Greencard P. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch. Gen. Psychiatry 2002, 59:705-712.
2. Assis L.C., Rezin G.T., Comim C.M., Valvassori S.S., Jeremias I.C., Zugno A.I., Quevedo J., Streck E.L. Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Rev. Bras. Psiquiatr. 2009, 31(3):247-252.
3. Baghai T.C., Grunze H., Sartorius N. Antidepressant medications and other treatments of depressive disorders: a CINP task force report based on a review of evidence. Int. J. Neuropsychopharmacol. 2007, 10(l):S1-S207.
4. Búrigo M., Roza C.A., Bassani C., Feier G., Dal-Pizzol F., Quevedo J., Streck E.L. Decreased creatine kinase activity caused by electroconvulsive shock. Neurochem. Res. 2006, 31:877-881.
5. Cannon T.D., Keller M.C. Endophenotypes in the genetic analyses of mental disorders. Annu. Rev. Clin. Psychol. 2006, 2:267-290.
6. Corrêa C., Amboni G., Assis L.C., Martins M.R., Kapczinski F., Streck E.L., Quevedo J. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:887-891.
7. Fattal O., Budur K., Vaughan A.J., Franco K. Review of the literature on major mental disorders in adult patients with mitochondrial diseases. Psychosomatics 2006, 47:1-7.
8. Fischer J.C., Ruitenbeek W., Berden J.A., Trijbels J.M., Veerkamp J.H., Stadhouders A.M., Sengers R.C., Janssen A.J. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin. Chim. Acta 1985, 153:23-36.
9. Sartorius N., Baghai T.C., Baldwin D.S., Barrett B., Brand U., Fleischhacker W., Goodwin G., Grunze H., Knapp M., Leonard B.E., Lieberman J., Nakane Y., Pinder R.M., Schatzberg A.F., Švestka J., Baumann P., Ghalib K., Markowitz J.C., Padberg F., Fink M., Furukawa T., Fountoulakis K.N., Jensen P., Kanba S., Riecher-Rössler A. Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence. Int. J. Neuropsychopharmacol. 2007, 10(l):S1-S207.
10. Gardner A., Johansson A., Wibom R., Nennesmo I., Von Döbeln U., Hagenfeldt L., Hällström T. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J. Affect. Disord. 2003, 76:55-68.
11. Kanarik M., Matrov D., Kõiv K., Eller M., Tõnissaar M., Harro J. Changes in regional long-term oxidative metabolism induced by partial serotonergic denervation and chronic variable stress in rat brain. Neurochem. Int. 2008, 52:432-437.
12. Kato T., Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2000, 2:180-190.
13. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51:8-19.
14. Kiss J.P. Theory of active antidepressants: a nonsynaptic approach to the treatment of depression. Neurochem. Int. 2008, 52:34-39.
15. Konradi C., Eaton M., MacDonald M.L., Walsh J., Benes F.M., Heckers S. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 2004, 61:300-308.
16. Longone P., Rupprecht R., Manieri G.A., Bernardi G., Romeo E., Pasini A. The complex roles of neurosteroids in depression and anxiety disorders. Neurochem. Int. 2008, 52:596-601.
17. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-267.
18. Madrigal J.L., Olivenza R., Moro M.A., Lizasoain I., Lorenzo P., Rodrigo J., Leza J.C. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001, 24:420-429.
19. Marco R., Pestaña A., Sebastian J., Alberto S. Oxaloacetate metabolic crossroads in liver. Enzyme compartmentation and regulation of gluconeogenesis. Mol. Cell. Biochem. 1974, 3:53-70.
20. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 2006, 110:135-370.
21. Morilak D.A., Frazer A. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int. J. Neuropsychopharmacol. 2007, 7:193-218.
22. Petrosillo G., Matera M., Casanova G., Ruggiero F.M., Paradies G. Mitochondrial dysfunction in rat brain with aging: involvement of complex I, reactive oxygen species and cardiolipin. Neurochem. Int. 2008, 53:126-131.
23. Prabakaran S., Swatton J.E., Ryan M.M., Huffaker S.J., Huang J.T., Griffin J.L., Wayland M., Freeman T., Dudbridge F., Lilley K.S., Karp N.A., Hester S., Tkachev D., Mimmack M.L., Yolken R.H., Webster M.J., Torrey E.F., Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry 2004, 9:684-697.
24. Rex A., Schickert R., Fink H. Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test in rats. Pharmacol. Biochem. Behav. 2004, 77:303-307.
25. Rezin G.T., Cardoso M.R., Gonçalves C.L., Scaini G., Fraga D.B., Riegel R.E., Comim C.M., Quevedo J., Streck E.L. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem. Int. 2008, 53:395-400.
26. Rustin P., Munnich A., Rötig A. Succinate dehydrogenase and human diseases: new insights into a well-known enzyme. Eur. J. Hum. Genet. 2002, 10:289-291.
27. Santos P.M., Scaini G., Rezin G.T., Benedet J., Rochi N., Jeremias G.C., Carvalho-Silva M., Quevedo J., Streck E.L. Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain Res. Bull. 2009, 80:327-330.
28. Schule C. Neuroendocrinological mechanisms of actions of antidepressant drugs. J. Neuroendocrinol. 2006, 19:213-226.
29. Shelton R.C. The molecular neurobiology of depression. Psychiatr. Clin. North Am. 2007, 30:1-11.
30. Shepherd D., Garland P.B. The kinetic properties of citrate synthase from rat liver mitochondria. Biochem. J. 1969, 114:597-610.
31. Srere P.A. Citrate synthase. Methods Enzymol. 1969, 13:3-11.
32. Stanyer L., Jorgensen W., Hori O., Clark J.B., Heales S.J. Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction. Neurochem. Int. 2008, 53:95-101.
33. +, K+-ATPase activity in the rat hippocampus. Neurosci. Lett. 2006, 404:254-257.
34. Streck E.L., Amboni G., Scaini G., Di-Pietro P.B., Rezin G.T., Valvassori S.S., Luz G., Kapczinski F., Quevedo J. Brain creatine kinase activity in an animal model of mania. Life Sci. 2008, 82:424-429.
35. Tretter L., Mayer-Takacs D., Adam-Vizi V. The effect of bovine serum albumin on the membrane potential and reactive oxygen species generation in succinate-supported isolated brain mitochondria. Neurochem. Int. 2007, 50:139-147.
36. Tyler D. The Mitochondrion in Health and Diseases 1992, VCH Publishers, New York.
37. Zarate C.A., Singh J.B., Carlson P.J., Brusche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., Manji H.K. A randomised trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiatry 2006, 63:856-864.